|
⚲
|
| Keyboard |
| Oaktree PRE Life Sciences Fund LP | |
|---|---|
| Firm |
Oaktree Capital Management LP
✚
|
| Fund # | 805-7363932380 |
| CIK # | |
| Sale | |
| Fund | Other Private Fund |
| Phone | |
| Address | |
| Source | [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | Oaktree PRE Strategic Life Sciences GP LP |
| Custodian | The Bank of New York Mellon, HSBC Continental Europe, Bank of New York Mellon Corporation |
| Auditor | Ernst & Young LLP |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Investors | 1 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Royale Asset Management LLC
✚
|
52.7 M | |
|
Wealthpro LLC
✚
|
52.4 M | |
|
Parkside Family Office LLC
✚
|
52.4 M | |
|
Acasta Partners UK LLP
✚
|
51.8 M | |
|
Oberweis Asset Management Hong Kong Limited
✚
|
51.8 M | |
|
Summer Creek Wealth Management LLC
✚
|
50.8 M | |
|
Sabbia Faro Wealth Management LLC
✚
|
50.6 M | |
|
Silver Capital Management LLC
✚
|
50.1 M | |
|
Toccata Capital LLC
✚
|
50.0 M | |
|
Pamalican Asset Management Limited
✚
|
50.0 M |